- Previous Close
15.80 - Open
14.55 - Bid 14.25 x --
- Ask 15.35 x --
- Day's Range
14.25 - 15.50 - 52 Week Range
11.25 - 25.50 - Volume
81,410 - Avg. Volume
202,327 - Market Cap (intraday)
2.209B - Beta (5Y Monthly) 0.22
- PE Ratio (TTM)
-- - EPS (TTM)
-0.67 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Pontex Polyblend Co., Ltd. engages in footwear injection molding and engineering plastics compound materials businesses in Taiwan, the Mainland of China, the United States, and internationally. It offers ABS, PC, nylon, PP, PBT, NPE, TPU, PLA, PBS, and r-PET plastic compound materials for applications in the areas of 3C/electronic products, industrial equipment parts, auto/moto parts, household goods, sports/toy parts, and medical supplies. The company also provides sports equipment, such as baseball, football, soccer, and bicycle outsoles; and shoe components, including midsoles, shanks, and counters, as well as sports shoes. In addition, it manufactures various women vamps injection products on an OEM basis for the CROCS brand. The company was incorporated in 1982 and is headquartered in Taichung City, Taiwan.
www.pontex.com195
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 8935.TWO
View MorePerformance Overview: 8935.TWO
Trailing total returns as of 4/8/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8935.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8935.TWO
View MoreValuation Measures
Market Cap
2.45B
Enterprise Value
2.72B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.14
Price/Book (mrq)
2.53
Enterprise Value/Revenue
4.92
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-13.26%
Return on Assets (ttm)
-3.42%
Return on Equity (ttm)
-8.00%
Revenue (ttm)
553.24M
Net Income Avi to Common (ttm)
-73.34M
Diluted EPS (ttm)
-0.67
Balance Sheet and Cash Flow
Total Cash (mrq)
168.17M
Total Debt/Equity (mrq)
46.15%
Levered Free Cash Flow (ttm)
-24.12M